440 related articles for article (PubMed ID: 19527332)
1. Safe botulinum toxin type A injection in patients with history of eyelid ptosis.
Ghalamkarpour F; Aghazadeh Y; Odabaei G
J Cosmet Dermatol; 2009 Jun; 8(2):98-102. PubMed ID: 19527332
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of 3- and 5-injection patterns (30 and 50 U) of botulinum toxin A (Dysport) for the treatment of wrinkles in the glabella and the central forehead region.
Rzany B; Ascher B; Fratila A; Monheit GD; Talarico S; Sterry W
Arch Dermatol; 2006 Mar; 142(3):320-6. PubMed ID: 16549707
[TBL] [Abstract][Full Text] [Related]
3. Anterior chemodenervation of levator palpebrae superioris with botulinum toxin type-A (Botox) to induce temporary ptosis for corneal protection.
Naik MN; Gangopadhyay N; Fernandes M; Murthy R; Honavar SG
Eye (Lond); 2008 Sep; 22(9):1132-6. PubMed ID: 17510652
[TBL] [Abstract][Full Text] [Related]
4. Clostridium botulinum type A toxin for the treatment of upper face animation lines: an Iranian experience.
Farahvash MR; Arad S
J Cosmet Dermatol; 2007 Sep; 6(3):152-8. PubMed ID: 17760691
[TBL] [Abstract][Full Text] [Related]
5. Eyebrow height after botulinum toxin type A to the glabella.
Carruthers A; Carruthers J
Dermatol Surg; 2007 Jan; 33(1 Spec No.):S26-31. PubMed ID: 17241411
[TBL] [Abstract][Full Text] [Related]
6. Long-term prospective follow-up of botulinum toxin treatment for facial rhytides.
Bulstrode NW; Grobbelaar AO
Aesthetic Plast Surg; 2002; 26(5):356-9. PubMed ID: 12432474
[TBL] [Abstract][Full Text] [Related]
7. Treatment of ptosis as a complication of botulinum toxin injection.
Omoigui S; Irene S
Pain Med; 2005; 6(2):149-51. PubMed ID: 15773880
[TBL] [Abstract][Full Text] [Related]
8. [Protective ptosis by botulinum A toxin injection in corneal affectations].
Gusek-Schneider GC; Erbguth F
Klin Monbl Augenheilkd; 1998 Jul; 213(1):15-22. PubMed ID: 9743934
[TBL] [Abstract][Full Text] [Related]
9. A multicenter, randomized, double-blind, placebo-controlled study of efficacy and safety of 3 doses of botulinum toxin A in the treatment of glabellar lines.
Ascher B; Zakine B; Kestemont P; Baspeyras M; Bougara A; Santini J
J Am Acad Dermatol; 2004 Aug; 51(2):223-33. PubMed ID: 15280841
[TBL] [Abstract][Full Text] [Related]
10. Paradoxical use of frontalis muscle and the possible role of botulinum a toxin in permanent motor relearning.
Ben Simon GJ; Blaydon SM; Schwarcz RM; Nakra T; Goldberg RA; McCann JD
Ophthalmology; 2005 May; 112(5):918-22. PubMed ID: 15878076
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin A injection into corrugator muscle for frontally localised chronic daily headache or chronic tension-type headache.
de Ru JA; Buwalda J
J Laryngol Otol; 2009 Apr; 123(4):412-7. PubMed ID: 18588738
[TBL] [Abstract][Full Text] [Related]
12. A single transcutaneous injection with Botox for dysthyroid lid retraction.
Shih MJ; Liao SL; Lu HY
Eye (Lond); 2004 May; 18(5):466-9. PubMed ID: 15131675
[TBL] [Abstract][Full Text] [Related]
13. [Frequency of side effects after botulinum toxin A injections in neurology, rehabilitation and gastroenterology].
Sławek J; Madaliński MH; Maciag-Tymecka I; Duzyński W
Pol Merkur Lekarski; 2005 Mar; 18(105):298-302. PubMed ID: 15997637
[TBL] [Abstract][Full Text] [Related]
14. Management of the ageing eyebrow and forehead: an objective dose-response study with botulinum toxin.
Levy JL; Pons F; Jouve E
J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):711-6. PubMed ID: 16836501
[TBL] [Abstract][Full Text] [Related]
15. New indications for botulinum toxin type A in treating facial wrinkles of the mouth and neck.
Spósito MM
Aesthetic Plast Surg; 2002; 26(2):89-98. PubMed ID: 12016492
[TBL] [Abstract][Full Text] [Related]
16. Transcutaneous dysport injection for treatment of upper eyelid retraction associated with thyroid eye disease.
Salour H; Bagheri B; Aletaha M; Babsharif B; Kleshadi M; Abrishami M; Bagheri A
Orbit; 2010 Apr; 29(2):114-8. PubMed ID: 20394553
[TBL] [Abstract][Full Text] [Related]
17. Pilot study comparing the diffusion of two formulations of botulinum toxin type A in patients with forehead hyperhidrosis.
Trindade de Almeida AR; Marques E; de Almeida J; Cunha T; Boraso R
Dermatol Surg; 2007 Jan; 33(1 Spec No.):S37-43. PubMed ID: 17241413
[TBL] [Abstract][Full Text] [Related]
18. Repeated botulinum-A toxin injections in the treatment of myelodysplastic children and patients with spinal cord injuries with neurogenic bladder dysfunction.
Akbar M; Abel R; Seyler TM; Bedke J; Haferkamp A; Gerner HJ; Möhring K
BJU Int; 2007 Sep; 100(3):639-45. PubMed ID: 17532858
[TBL] [Abstract][Full Text] [Related]
19. Supraciliary wrinkles and botulinum toxin A.
Ghalamkarpour F; Robati RM; Aryanejad F; Toossi P
Clin Exp Dermatol; 2010 Jun; 35(4):388-91. PubMed ID: 19874314
[TBL] [Abstract][Full Text] [Related]
20. [Prevention and management of locoregional complications of botulinum A toxin injections in cosmetic treatment].
Gassia V
Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S146-51. PubMed ID: 19576482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
